IRB Continuing Review After Clinical Investigation Approval: Guidance for IRBs, Clinical Investigators, and Sponsors
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
February 27, 2012
April 24, 2020
7c18de8c-1544-4b72-a67a-3a861d29c31c
Related Documents
IRB Responsibilities for Reviewing the Qualifications of Investigators, Adequacy of Research Sites, and the Determination of Whether an IND/IDE is Needed: Guidance for IRBs, Clinical Investigators, and Sponsors
Guidance DocumentAugust 27, 2013Office of the Commissioner
Considerations When Transferring Clinical Investigation Oversight to Another IRB: Guidance for IRBs, Clinical Investigators, and Sponsors
Guidance DocumentMay 23, 2014Office of the Commissioner
Q11 Development and Manufacture of Drug Substances
Guidance DocumentNovember 20, 2012Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.